Ihl got to 1b on a pump (listing over seas) and emd is arguably further along in its clinical trials (10,000 people and it's data) have more robust synthetic drugs, have manufacturing agreement and has better backing with its data. (from the first tga approved capture Device through to the RWD system and clinics and Jazz pharma / palantar & fda RWD experience.
